Association of MORC2 expression with progression-free survival in cervical cancer patients treated with concurrent chemoradiotherapy
Open Access
- 20 September 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (38) , e39299
Abstract
MORC family CW-type zinc finger 2 (MORC2) is a newly identified chromatin remodeling protein, and has been proposed as a prognostic biomarker associated with survival in some types of human cancer, but the role of MORC2 in cervical cancer remains unknown. Here, we investigated the role of MORC2 expression in predicting the survival outcomes of locally advanced cervical cancer patients treated with cisplatin-based concurrent chemoradiotherapy (CCRT). In this retrospectively study, we detected MORC2 immunohistochemical expression on 55 biopsies from patients who underwent CCRT. The association between the MORC2 expression and various clinicopathological characteristics were analyzed, as were association between MORC2 expression and locoregional failure and progression-free survival (PFS) of cervical cancer patients. MORC2 expression was positively associated with pelvic node metastasis and locoregional failure. Higher MORC2 expression was a significant indicator of worse PFS. Our results suggest that MORC2 expression may be a prognostic indicator in patients with locally advanced cervical cancer undergoing CCRT.Keywords
This publication has 22 references indexed in Scilit:
- MORC2/β-catenin signaling axis promotes proliferation and migration of breast cancer cellsMedical Oncology, 2022
- O-GlcNAcylation of MORC2 at threonine 556 by OGT couples TGF-β signaling to breast cancer progressionCell Death & Differentiation, 2022
- MORC2 Interactome: Its Involvement in Metabolism and CancerBiophysical Reviews, 2021
- The chromatin modifier MORC2 affects glucose metabolism by regulating the expression of lactate dehydrogenase A through a feed forward loop with c‐MycFEBS Letters, 2021
- FIGO 2018 staging criteria for cervical cancer: Impact on stage migration and survivalGynecologic Oncology, 2020
- Acetylation of MORC2 by NAT10 regulates cell-cycle checkpoint control and resistance to DNA-damaging chemotherapy and radiotherapy in breast cancerNucleic Acids Research, 2020
- Stabilization of MORC2 by estrogen and antiestrogens through GPER1- PRKACA-CMA pathway contributes to estrogen-induced proliferation and endocrine resistance of breast cancer cellsAutophagy, 2019
- MORC2 regulates DNA damage response through a PARP1-dependent pathwayNucleic Acids Research, 2019
- Aberrant high expression level of MORC2 is a common character in multiple cancersHuman Pathology, 2018
- Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapyThe Lancet Oncology, 2018